AMEREN CORP

For the period ended Mar 31, 2025. Filed May 5, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 5, 2025

AEE$114.02+1.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheet

CONSOLIDATED BALANCE SHEET

	March 31,2025	December 31, 2024
ASSETS
Current Assets:
Cash and cash equivalents	$7	$—
Advances to money pool	—	43
Accounts receivable – trade (less allowance for doubtful accounts of $12 and $12, respectively)	236	209
Accounts receivable – affiliates	44	40
Unbilled revenue	128	170
Miscellaneous accounts receivable	272	33
Inventories	472	514
Current regulatory assets	119	66
Other current assets	85	70
Total current assets	1,363	1,145
Property, Plant, and Equipment, Net	19,228	18,788
Investments and Other Assets:
Nuclear decommissioning trust fund	1,312	1,342
Regulatory assets (includes $459 and $465 related to VIEs, respectively)	1,401	1,366
Pension and other postretirement benefits	212	211
Other assets	239	254
Total investments and other assets	3,164	3,173
TOTAL ASSETS	$23,755	$23,106
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Current maturities of long-term debt (includes $17 and $17 related to VIEs, respectively)	$17	$17
Short-term debt	629	—
Accounts and wages payable	335	629
Accounts payable – affiliates	42	50
Taxes accrued	77	29
Interest accrued	70	88
Other current liabilities	199	206
Total current liabilities	1,369	1,019
Long-term Debt, Net (includes $449 and $448 related to VIEs, respectively)	7,672	7,671
Long-term Debt, Net - Related Parties	57	57
Deferred Credits and Other Liabilities:
Accumulated deferred income taxes and tax credits, net	2,488	2,217
Regulatory liabilities	3,177	3,176
Asset retirement obligations	826	818
Other deferred credits and liabilities	176	150
Total deferred credits and other liabilities	6,667	6,361
Commitments and Contingencies (Notes 2, 8, 9, and 10)
Shareholders’ Equity:
Common stock, $5 par value, 150.0 shares authorized – 102.1 shares outstanding	511	511
Other paid-in capital, principally premium on common stock	3,201	3,201
Preferred stock	80	80
Retained earnings	4,198	4,206
Total shareholders’ equity	7,990	7,998
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$23,755	$23,106

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.